Australia
· Delayed Price · Currency is AUD Mayne Pharma Group Company Description
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
The company operates through three segments: Women’s Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas.
The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010.
Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
| Country | Australia |
| Founded | 2005 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 967 |
| CEO | Shawn O’Brien |
Contact Details
Address: 1538 Main North Road Salisbury South, Victoria 5106 Australia | |
| Phone | 61 8 8209 2666 |
| Website | maynepharma.com |
Stock Details
| Ticker Symbol | MYX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000MYX0 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shawn Patrick O'Brien B.Sc | Chief Executive Officer, MD and Director |
| Aaron Gray | Chief Financial Officer |
| Kimberly Parker J.D. | Executive Vice President and General Counsel |
| Brant Schofield | Executive Vice President of Corporate Development |
| Erinn Nathaniel | Director of Global Human Resources |
| Daniel Moore | Executive Vice President of Commercial |
| Dr. Frank Casty M.D. | Executive Vice President and Global Chief Medical Officer |
| Brenton Walter | Financial Controller |
| Laura Loftus | Associate General Counsel and Company Secretary |